Studies

Created At
Go
17 Studies visible to you, out of a total of 17

Mega-CHOEP phase III is a randomised study comparing conventional chemoimmunotherapy with R-CHOEP-14 with high-dose chemotherapy plus Rituximab with autologous stem cell transplantation in high-risk patients aged 61 to 80 years with Aggressive Non-Hodgkin’s Lymphoma.

Submitter: René Hänsel

Investigation: MegaCHOEP Phase III

Resources: No Resources

Study type: Not specified

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival) Sample Size: 103

Submitter: René Hänsel

Investigation: Pegfilgrastim

Resources: Pegfilgrastim metadata, Pegfilgrastim trial data

Study type: Not specified

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Investigation: RICOVER-noRTh

Resources: RICOVER-noRTh metadata, RICOVER-noRTh trial data

Study type: Not specified

Demographics, reference pathology diagnosis, Outcome (Event-free survival, Progression-free survival, Overall survival)

Submitter: René Hänsel

Investigation: RICOVER-60

Resources: RICOVER-60 trial data, RICOVER-60 trial metadata

Study type: Not specified

No description specified

Submitter: René Hänsel

Investigation: MInT

Resources: MInT trial data, MInt Trial Result Metadata

Study type: Not specified

No description specified

Submitter: René Hänsel

Investigation: MegaCHOEP

Resources: MegaCHOEP Trial Metadata, MegaCHOEP trial data

Study type: Not specified

No description specified

Submitter: René Hänsel

Investigation: MegaCHOEP phase 2 (Glass 2006, Schmitz 2006, Gl...

Resources: No Resources

Study type: Not specified

Powered by
(v.1.13.0-master)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

By continuing to use this site you agree to the use of cookies